Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer

NCT00052312 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

141

Enrollment

NETWORK

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: cisplatin
DRUG: doxorubicin hydrochloride
DRUG: paclitaxel

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC